These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 2775622)

  • 21. Inhibition of coumarin 7-hydroxylase activity in human liver microsomes.
    Draper AJ; Madan A; Parkinson A
    Arch Biochem Biophys; 1997 May; 341(1):47-61. PubMed ID: 9143352
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Alterations induced by the antifungal compounds ketoconazole and terbinafine in Leishmania.
    Vannier-Santos MA; Urbina JA; Martiny A; Neves A; de Souza W
    J Eukaryot Microbiol; 1995; 42(4):337-46. PubMed ID: 7620457
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Use of isolated hepatocyte preparations for cytochrome P450 inhibition studies: comparison with microsomes for Ki determination.
    Brown HS; Chadwick A; Houston JB
    Drug Metab Dispos; 2007 Nov; 35(11):2119-26. PubMed ID: 17724064
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Metabolism of endosulfan-alpha by human liver microsomes and its utility as a simultaneous in vitro probe for CYP2B6 and CYP3A4.
    Casabar RC; Wallace AD; Hodgson E; Rose RL
    Drug Metab Dispos; 2006 Oct; 34(10):1779-85. PubMed ID: 16855053
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Ketoconazole and fluconazole inhibition of the metabolism of cyclosporin A by human liver in vitro.
    Omar G; Whiting PH; Hawksworth GM; Humphrey MJ; Burke MD
    Ther Drug Monit; 1997 Aug; 19(4):436-45. PubMed ID: 9263386
    [TBL] [Abstract][Full Text] [Related]  

  • 26. In vitro metabolism and inhibitory effects of pranlukast in human liver microsomes.
    Yoneda K; Matsumoto I; Sutoh F; Higashi R; Nunoya K; Nakade S; Miyata Y; Ogawa M
    Biol Pharm Bull; 2009 Apr; 32(4):688-93. PubMed ID: 19336906
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Inhibition of ethinyloestradiol and tolbutamide metabolism by quinoline derivatives in vitro.
    Riviere JH; Back DJ
    Chem Biol Interact; 1986 Oct; 59(3):301-8. PubMed ID: 3769058
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Triazolam biotransformation by human liver microsomes in vitro: effects of metabolic inhibitors and clinical confirmation of a predicted interaction with ketoconazole.
    von Moltke LL; Greenblatt DJ; Harmatz JS; Duan SX; Harrel LM; Cotreau-Bibbo MM; Pritchard GA; Wright CE; Shader RI
    J Pharmacol Exp Ther; 1996 Feb; 276(2):370-9. PubMed ID: 8632299
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Role of cytochrome P-4502C9 in irbesartan oxidation by human liver microsomes.
    Bourrié M; Meunier V; Berger Y; Fabre G
    Drug Metab Dispos; 1999 Feb; 27(2):288-96. PubMed ID: 9929518
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Inhibition of rat liver microsomal cytochrome P-450 steroid hydroxylase reactions by imidazole antimycotic agents.
    Sheets JJ; Mason JI; Wise CA; Estabrook RW
    Biochem Pharmacol; 1986 Feb; 35(3):487-91. PubMed ID: 3947383
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Mechanism of action and biochemical selectivity of allylamine antimycotic agents.
    Ryder NS
    Ann N Y Acad Sci; 1988; 544():208-20. PubMed ID: 3063168
    [No Abstract]   [Full Text] [Related]  

  • 32. CYP2C19 participates in tolbutamide hydroxylation by human liver microsomes.
    Wester MR; Lasker JM; Johnson EF; Raucy JL
    Drug Metab Dispos; 2000 Mar; 28(3):354-9. PubMed ID: 10681382
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Human liver cytochrome P4503A biotransformation of the cyclosporin derivative SDZ IMM 125.
    Vickers AE; Meyer E; Dannecker R; Keller B; Tynes RE; Maurer G
    Drug Metab Dispos; 1995 Mar; 23(3):321-6. PubMed ID: 7628296
    [TBL] [Abstract][Full Text] [Related]  

  • 34. In vivo effects of terbinafine and ketoconazole on testosterone plasma levels in healthy males.
    Effendy I; Krause W
    Dermatologica; 1989; 178(2):103-6. PubMed ID: 2924980
    [TBL] [Abstract][Full Text] [Related]  

  • 35. An inhibition study of beauvericin on human and rat cytochrome P450 enzymes and its pharmacokinetics in rats.
    Mei L; Zhang L; Dai R
    J Enzyme Inhib Med Chem; 2009 Jun; 24(3):753-62. PubMed ID: 18956271
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Experimental chemotherapy with combinations of ergosterol biosynthesis inhibitors in murine models of Chagas' disease.
    Maldonado RA; Molina J; Payares G; Urbina JA
    Antimicrob Agents Chemother; 1993 Jun; 37(6):1353-9. PubMed ID: 8328786
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effect of mefloquine on hepatic drug metabolism in the rat: comparative study with primaquine.
    Riviere JH; Back DJ
    Biochem Pharmacol; 1985 Feb; 34(4):567-71. PubMed ID: 3871613
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Inhibition of hepatic microsomal enzymes by gossypol in the rat.
    Ma XN; Back DJ
    Contraception; 1984 Jul; 30(1):89-97. PubMed ID: 6478834
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Differential inhibition of fungal amd mammalian squalene epoxidases by the benzylamine SDZ SBA 586 in comparison with the allylamine terbinafine.
    Favre B; Ryder NS
    Arch Biochem Biophys; 1997 Apr; 340(2):265-9. PubMed ID: 9143330
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Inhibition of CYP3A4 and CYP3A5 catalyzed metabolism of alprazolam and quinine by ketoconazole as racemate and four different enantiomers.
    Allqvist A; Miura J; Bertilsson L; Mirghani RA
    Eur J Clin Pharmacol; 2007 Feb; 63(2):173-9. PubMed ID: 17200836
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.